Surprises lead to deceleration of overall Orthobio growth For Q419, US Orthobio market growth (comprised...
Overall, 2019 was a good recovery year for the US Joint Fluid market with Single-injection treatment opt...
Here are some highlights of recently announced trials in OrthoBio that were picked up by our analysts, p...
Easy YoY comps along with new product introductions help drive sequential growth SmartTRAK reports that ...
With a boost from an extra selling day during the third quarter, the US OrthoBio Market continues to be ...
SmartTRAK's Senior Regenerative Medicine Analyst, Freddy Buntoum, attended TOBI 2019 this summer. Here's...